

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Aug 28, 26 | Kedia Gunjan | director, officer: President & CEO | M-Exempt | 27,267 @ $55.01 | $1.50M |
Daily · Wilder smoothing
| Aug 28, 26 |
| Kedia Gunjan |
| director, officer: President & CEO |
| S-Sale |
| 27,267 @ $62.37 |
| $1.70M |
| Aug 28, 26 | Kedia Gunjan | director, officer: President & CEO | M-Exempt | 27,267 @ $55.01 | $1.50M |
| Jul 23, 26 | Chosy James L | officer: Senior EVP and General Counsel | M-Exempt | 24,711 @ $55.01 | $1.36M |
| Jul 23, 26 | Chosy James L | officer: Senior EVP and General Counsel | S-Sale | 22,968 @ $63.28 | $1.45M |
| Jul 23, 26 | Chosy James L | officer: Senior EVP and General Counsel | M-Exempt | 24,711 @ $55.01 | $1.36M |
| Jul 21, 26 | Chosy James L | officer: Senior EVP and General Counsel | G-Gift | 3,969 | — |
| Jul 20, 26 | Philipson Stephen L | officer: Vice Chair | S-Sale | 36,906 @ $63.08 | $2.33M |
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 54.83 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 91.91 | Oscillator | Sell |
| Williams %R (14) | -9.32 | Oscillator | Sell |
| MACD (12, 26, 9) | -0.23 (Hist 0.48) | Oscillator | Buy |
| Average Directional Index (14) | 26.74 (+DI 24.7 / -DI 21.7) | Trend | Strong Buy |
| EMA 20 | 58.56 | MA | Buy |
| SMA 20 | 57.84 | MA | Strong Buy |
| EMA 50 | 59.55 | MA | Buy |
| SMA 50 | 60.29 | MA | Sell |
| SMA 200 | 57.92 | MA | Buy |
Stock news · updated daily
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
A proposed federal drug-discount overhaul could quietly funnel billions in new borrowing demand toward the banks already holding hospital credit lines, and the lenders best positioned to profit may surprise you.
Moving up the dividend yield ladder from a chipmaker near 2% to a package carrier above 6% sounds like a straightforward trade, but each step strips away something you probably assumed you were keeping.
U.S. Bancorp delivered solid third-quarter results, with net interest income up 5.6% and diluted EPS increasing 9.8% year over year. Management expects continued growth, supported by higher fee revenue, capital markets, and the BTIG acquisition. Credit quality remains manageable, but rising credit-loss provisions and broader economic vulnerabilities warrant caution.
NEW YORK--(BUSINESS WIRE)--BTIG, a U.S. Bancorp company, announced today that Bhavesh Lodaya has joined the firm as a Director and Chemicals Analyst. “We see chemicals as an important growth area for our research franchise, and I am excited to welcome Bhavesh as the analyst who will help establish our coverage in this sector,” said Ryan Serwin, CFA, Director of Research at U.S. Bancorp | BTIG. “His industry knowledge, investment perspective, and client focus will be instrumental as we expand ou.
First Bank and Trust grew its stake in U.S. Bancorp (NYSE: USB) by 43.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 133,794 shares of the financial services provider's stock after buying an additional 40,208 shares
I'm maintaining Buy on PNC Financial Services and Hold on U.S. Bancorp for new money after solid Q3 results from both. PNC repurchased ~$560M of stock in Q3. USB bought none because it is rebuilding its capital ratio as it prepares for stricter Category II rules. PNC's loan growth is mostly organic and its ROTCE rose, though loans are growing faster than deposits. USB's margin is widening but its BTIG acquisition has added little so far.
Deutsche Bank is weeks away from letting German institutions park Bitcoin and Ether with a regulated custodian, and the move raises a bigger question: will a wave of bank entries finally translate into lasting price pressure, or just more plumbing for demand that has yet to show up?
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Oct 15, 2026 | 1.32 | 1.34 | Beat 1.5% | $7.97B |
| Jul 16, 2026 | 1.28 | 1.35 | Beat 5.5% | $7.71B |
| Apr 16, 2026 | 1.14 | 1.18 | Beat 3.5% | $7.29B |
| Jan 20, 2026 | 1.19 | 1.26 | Beat 5.9% | $7.36B |
| Oct 16, 2025 | 1.13 | 1.22 | Beat 8.0% | $7.30B |
| Jul 17, 2025 | 1.07 | 1.11 | Beat 3.7% | $6.97B |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 424B3 | Oct 22, 2026 | 2026-10-22 12:49:58 | View |
| 424B3 | Oct 22, 2026 | 2026-10-22 12:46:29 | View |
| 424B3 | Oct 22, 2026 | 2026-10-22 12:43:03 | View |
| 424B3 | Oct 22, 2026 | 2026-10-22 12:39:41 | View |
| 424B2 | Oct 22, 2026 | 2026-10-22 10:45:28 | View |
| FWP | Oct 21, 2026 | 2026-10-21 16:07:59 | View |
| 424B3 | Oct 21, 2026 | 2026-10-21 08:45:52 | View |
| 424B3 | Oct 20, 2026 | 2026-10-20 13:56:10 | View |
| 424B3 | Oct 20, 2026 | 2026-10-20 13:52:41 | View |
| 424B3 | Oct 19, 2026 | 2026-10-19 12:32:05 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | USB | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 11.6x | 12.0x · sector 20.4x | Discount |
| Forward P/E (FY26E) | 11.3x | EPS est. 5.28 | In line |
| Price / Book | 1.4x | 1.3x | In line |
| Price / Sales | 2.1x | 2.2x | In line |
| EV / EBITDA | 8.1x | 10.0x | Discount |
| Return on equity | 12.6% | — | Healthy |
| Gross margin | 64.7% | 73.4% | In line |
| Debt / Equity | 1.10 | 1.17 | Moderate |
| Piotroski / Altman Z | 8/9 | Z -0.21 | Distress |
Discounted cash flow model
FY2025 · 10-K disclosure
FY2012 · 10-K disclosure
Current price $59.63
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 16, 26 |
| Citigroup |
| maintain |
| Buy |
| Buy |
| Oct 16, 26 | Evercore ISI Group | maintain | Outperform | Outperform |
| Oct 16, 26 | DA Davidson | maintain | Buy | Buy |
| Oct 16, 26 | RBC Capital | maintain | Outperform | Outperform |
| Oct 16, 26 | Oppenheimer | maintain | Outperform | Outperform |
| Oct 6, 26 | Raymond James | maintain | Strong Buy | Strong Buy |
| Oct 5, 26 | UBS | maintain | Neutral | Neutral |
| Oct 2, 26 | JP Morgan | maintain | Neutral | Neutral |
| Oct 1, 26 | Truist Securities | maintain | Buy | Buy |